Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ciceri, Fabio  [Clear All Filters]
2019
Girmenia, C., Lazzarotto, T., Bonifazi, F., Patriarca, F., Irrera, G., Ciceri, F., Aversa, F., Citterio, F., Cillo, U., Cozzi, E., et al. (2019). Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO and AMCLI societies.Clin Transplante13666.
Peccatori, J., Mastaglio, S., Giglio, F., Greco, R., Crocchiolo, R., Patriarca, F., Forno, B., Deola, S., Assanelli, A., Stanghellini, M.Teresa Lup, et al. (2019). Clofarabine and Treosulfan as conditioning for matched related and unrelated HSCT: results from the phase II trial "Clo3o".Biol Blood Marrow Transplant.
Santoro, N., Labopin, M., Ciceri, F., van Lint, M.Teresa, Nasso, D., Blaise, D., Arcese, W., Tischer, J., Bruno, B., Ehninger, G., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.Cancer.
Marktel, S., Scaramuzza, S., Cicalese, M.Pia, Giglio, F., Galimberti, S., Lidonnici, M.Rosa, Calbi, V., Assanelli, A., Bernardo, M.Ester, Rossi, C., et al. (2019). Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.Nat Med.
Ferrua, F., Cicalese, M.Pia, Galimberti, S., Giannelli, S., Dionisio, F., Barzaghi, F., Migliavacca, M., Bernardo, M.Ester, Calbi, V., Assanelli, A.Angelo, et al. (2019). Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.Lancet Haematol.
Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.
Beelen, D.Wilhelm, Trenschel, R., Stelljes, M., Groth, C., Masszi, T., Reményi, P., Wagner-Drouet, E.-M., Hauptrock, B., Dreger, P., Luft, T., et al. (2019). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 .Lancet Haematol.